These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23337655)

  • 1. Laser acupuncture for depression: a randomised double blind controlled trial using low intensity laser intervention.
    Quah-Smith I; Smith C; Crawford JD; Russell J
    J Affect Disord; 2013 Jun; 148(2-3):179-87. PubMed ID: 23337655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser acupuncture for mild to moderate depression in a primary care setting--a randomised controlled trial.
    Quah-Smith JI; Tang WM; Russell J
    Acupunct Med; 2005 Sep; 23(3):103-11. PubMed ID: 16259308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
    Rush AJ; Trivedi MH; Ibrahim HM; Carmody TJ; Arnow B; Klein DN; Markowitz JC; Ninan PT; Kornstein S; Manber R; Thase ME; Kocsis JH; Keller MB
    Biol Psychiatry; 2003 Sep; 54(5):573-83. PubMed ID: 12946886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.
    Docherty JP; Sack DA; Roffman M; Finch M; Komorowski JR
    J Psychiatr Pract; 2005 Sep; 11(5):302-14. PubMed ID: 16184071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial.
    Bergfeld IO; Mantione M; Hoogendoorn ML; Ruhé HG; Notten P; van Laarhoven J; Visser I; Figee M; de Kwaasteniet BP; Horst F; Schene AH; van den Munckhof P; Beute G; Schuurman R; Denys D
    JAMA Psychiatry; 2016 May; 73(5):456-64. PubMed ID: 27049915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo.
    Dunlop BW; Reddy S; Yang L; Lubaczewski S; Focht K; Guico-Pabia CJ
    J Clin Psychopharmacol; 2011 Oct; 31(5):569-76. PubMed ID: 21869698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain Reduction After Laser Acupuncture Treatment in Geriatric Patients with Knee Osteoarthritis: a Randomized Controlled Trial.
    Helianthi DR; Simadibrata C; Srilestari A; Wahyudi ER; Hidayat R
    Acta Med Indones; 2016 Apr; 48(2):114-21. PubMed ID: 27550880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study.
    Montgomery SA; Mansuy L; Ruth A; Bose A; Li H; Li D
    J Clin Psychiatry; 2013 Apr; 74(4):363-9. PubMed ID: 23656841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture for comorbid depression and insomnia in perimenopause: A feasibility patient-assessor-blinded, randomized, and sham-controlled clinical trial.
    Zhao FY; Zheng Z; Fu QQ; Conduit R; Xu H; Wang HR; Huang YL; Jiang T; Zhang WJ; Kennedy GA
    Front Public Health; 2023; 11():1120567. PubMed ID: 36815166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of telephone-based cognitive behavioral therapy targeting major depression among urban dwelling African-American people with co-occurring HIV.
    Himelhoch S; Mohr D; Maxfield J; Clayton S; Weber E; Medoff D; Dixon L
    Psychol Health Med; 2011 Mar; 16(2):156-65. PubMed ID: 21328144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of acupuncture monotherapy in patients with major depressive disorder.
    Mischoulon D; Brill CD; Ameral VE; Fava M; Yeung AS
    J Affect Disord; 2012 Dec; 141(2-3):469-73. PubMed ID: 22521855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.